Drugs / MPB-1514
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03485053 | Nov 2018 → Sep 2020 | iron deficiency anemia | MegaPro Biomedical Co. Ltd. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPB-1514 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03485053 ↗ |
| Known as | IOP Injection | “The purpose is to evaluate the efficacy and safety of IOP Injection (MPB-1514) for the treatment of iron-deficient anemia (IDA).” NCT03485053 ↗ |
| Route | Intravenous | “Administered IV infusion” NCT03485053 ↗ |